JNJ
-
Australian J&J hip lawsuit attracts hundreds, may top $200M | Legal News
April 25, 2012 by MassDevice staff Johnson & Johnson’s metal-on-metal hip replacement recall spurs a class action lawsuit Down Under, with more…
Read More » -
Extremities
J&J Wins EU Approval for $21.3 Billion Synthes Acquisition
Johnson & Johnson (JNJ) won European Union approval for its $21.3 billion purchase ofSynthes Inc. (SYST) after agreeing to sell its DePuy…
Read More » -
Extremities
Biomet Announces Offer to Acquire DePuy Trauma Business
WARSAW, Ind.–(BUSINESS WIRE)–Biomet, Inc. a global leader in the manufacture of musculoskeletal medical products, announced today that it has made…
Read More » -
DePuy Unloads ASR Hip Implant Inventory After Problems Were Known
In 2009 after the U.S. Food and Drug Administration raised questions about the safety of the DePuy ASR Hip Implants…
Read More » -
Biologics
Families Sue Synthes Over Bone Cement
The families of two patients who died during surgery that used an unapproved Synthes, Inc. bone cement are suing. A…
Read More » -
Extremities
Synthes gets warning letter over complaint management
Swiss medical device manufacturer Synthes has received a warning letter from U.S. regulators taking issue with the company’s management of…
Read More » -
J&J hip recall: Internal emails detail FDA’s non-approvable letter
A newly uncovered Johnson & Johnson (NYSE:JNJ) email may pose problems for the health care giant in the ongoing lawsuits…
Read More » -
Gorsky to succeed Weldon as CEO of Johnson & Johnson
The board of directors of Johnson & Johnson has named Alex Gorsky chief executive officer of Johnson & Johnson effective…
Read More » -
J&J Defends Synthes Bid at European Union Antitrust Hearing
Feb. 14 (Bloomberg) — Johnson & Johnson defended its planned acquisition of orthopedics maker Synthes Inc. at a meeting with…
Read More » -
Recon
J&J’s Depuy to stop selling all custom devices in response to FDA warning
Johnson & Johnson subsidiary Depuy Orthopaedics decides to stop selling all custom devices following an FDA letter warning the company…
Read More » -
Spine
DePuy Spine Launches Systems for Neuromuscular Scoliosis
DePuy Spine Inc. announces the launch of the EXPEDIUM Neuromuscular System, a new modular system of pre-contoured rods and proximal connectors,…
Read More » -
Spine
EU Opens In-Depth Probe Into Johnson & Johnson Deal for Synthes
Nov. 4 (Bloomberg) — European Union antitrust regulators opened an in-depth probe into Johnson & Johnson’s proposed acquisition of Synthes…
Read More » -
Recon
Zimmer, Stryker May Seek Orthopedic Purchases to Keep Pace After J&J Deal
Johnson & Johnson’s newfound dominance of the orthopedic-device market, cemented by its $21.3 billion acquisition of Synthes Inc. (SYST), may drive…
Read More » -
Extremities
Johnson & Johnson CFO: Synthes deal doesn’t mean we’re done
Johnson & Johnson (NYSE:JNJ) may have just dropped a cool $21.3 billion to acquire Synthes (SWX:SYST.VX), but it doesn’t mean…
Read More »